Jean-Paule Castagno and Attilio Mazzilli lead Orrick, Herrington & Sutcliffe’s team, which assists with the acquisitions and provides administrative, regulatory, and procurement advice to medtech clients. Castagno focuses on compliance matters, including strengthening internal control systems and implementing the Italian Sunshine Act, while also representing private individuals in criminal proceedings. Mazzilli focuses on investments and financing, while Rome-based Andrea Mezzetti handles data protection matters, ensuring compliance with the NIS2 Directive and advising on product launches under European regulatory frameworks.
Legal 500 Editorial commentary
Key clients
- Bianalisi S.p.A.
- Indaco Ventures Partners
Work highlights
Advised Indaco Venture Partners on its investment in the Series A financing of Tes Pharma, an Italy-based biotech company focused on delivering proprietary first-in-class drug candidates for oncology, renal and metabolic diseases.
Advised Bianalisi on the acquisition of two new networks of diagnostic centres, both local benchmarks for the quality of their technological equipment, Lucea.
Practice head
Jean-Paule Castagno; Attilio Mazzilli
Other key lawyers
Andrea Mezzetti